Express

NASDAQ-listed company LIXTE Biotechnology initiates crypto reserve strategy, plans to allocate 25% of funds to BTC

Summary: According to reports, NASDAQ-listed company LIXTE Biotechnology has announced that its board has approved a strategic capital allocation plan to acquire cryptocurrencies as part of the company's funds. The board has also approved allocating 25% of funds to cryptocurrencies, including Bitcoin and other potential digital assets (as appropriate).

According to reports, NASDAQ-listed company LIXTE Biotechnology has announced that its board has approved a strategic capital allocation plan to acquire cryptocurrencies as part of the company's funds. The board has also approved allocating 25% of funds to cryptocurrencies, including Bitcoin and other potential digital assets (as appropriate).

Last Update:

Tags:
Link: NASDAQ-listed company LIXTE Biotechnology initiates crypto reserve strategy, plans to allocate 25% of funds to BTC [Copy]

Last: President Trump considers two individuals for Federal Reserve Chairman position

Next: Three Addresses Recently Withdraw a Total of $1.172 Million Worth of BGB from Bitget

The Crypto Treasury Boom Meets Regulatory Chill: Is the DAT Frenzy Fading? 2 days ago

Nasdaq Takes Aim at 'Crypto-Flipping' Companies with Stricter Rules 6 days ago

BTC Weekly Outlook: The Oversold Bounce—A Bottom or a Shorting Opportunity? 9 days ago

The Making of a Political Darling: Is Chainlink’s Government Deal a Victory for Tech or... 13 days ago

Google Steps Into Blockchain: A New Front in the “Ledger Wars” 15 days ago